Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests

Arthritis and Rheumatism

Volumn 62, Issue 5, 2010, Pages 1478-1486

  Hanly, John G ^a   Omisade, Antonina ^a   Su, Li ^b   Farewell, Vernon ^b   Fisk, John D ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BETA INTERFERON; ETANERCEPT; INFLIXIMAB;

ADULT; ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; COGNITION; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HEALTH STATUS; HUMANS; LEAST-SQUARES ANALYSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77951706193     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27404     Document Type: Article

References (46)

1. Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, et al, for the Systemic Lupus International Collaborating Clinics. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56:265-273
2. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986;174:357-364 (Pubitemid 16084918)
3. Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992;19:562-567
4. Ginsburg KS, Wright EA, Larson MG, Fossel AH, Albert M, Schur PH, et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992;35:776-782
5. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996;39:2035-2045 (Pubitemid 27009072)
6. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58:1214-1220 (Pubitemid 34411865)
7. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
8. Reeves DL, Winter KP, Bleiberg J, Kane RL. ANAM genogram: historical perspectives, description, and current endeavors. Arch Clin Neuropsychol 2007;22 Suppl 1:S15-37.
9. Reeves DL, Kane R, Winter K. Automated Neuropsychological Assessment Metrics (ANAM V3.11a/96) user's manual: clinical and neurotoxicology subset (Report No. NCRF-SR-96-01). San Diego (CA): National Cognitive Foundation; 1996.
10. Bleiberg J, Kane RL, Reeves DL, Garmoe WS, Halpern E. Factor analysis of computerized and traditional tests used in mild brain injury research. Clin Neuropsychol 2000;14:287-294 (Pubitemid 32127924)
11. Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 2002;53:401-433
12. Reicker LI, Tombaugh TN, Walker L, Freedman MS. Reaction time: an alternative method for assessing the effects of multiple sclerosis on information processing speed. Arch Clin Neuropsychol 2007;22:655-664 (Pubitemid 46921428)
13. Tombaugh TN, Rees L, Stormer P, Harrison AG, Smith A. The effects of mild and severe traumatic brain injury on speed of information processing as measured by the computerized tests of information processing (CTIP). Arch Clin Neuropsychol 2007;22: 25-36. (Pubitemid 46217842)
14. Bleiberg J, Garmoe WS, Halpern EL, Reeves DL, Nadler JD. Consistency of within-day and across-day performance after mild brain injury. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10:247-253 (Pubitemid 27477902)
15. Levinson DM, Reeves DL. Monitoring recovery from traumatic brain injury using automated neuropsychological assessment metrics (ANAM V1.0). Arch Clin Neuropsychol 1997;12:155-166
16. Levinson D, Reeves D, Watson J, Harrison M. Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease. Arch Clin Neuropsychol 2005; 20:403-408 (Pubitemid 40431784)
17. Wilken JA, Kane R, Sullivan CL, Wallin M, Usiskin JB, Quig ME, et al. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2003;9:119-127 (Pubitemid 36426985)
18. Roebuck-Spencer TM, Yarboro C, Nowak M, Takada K, Jacobs G, Lapteva L, et al. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Rheum 2006;55: 434-441 (Pubitemid 43887030)
19. Brunner HI, Ruth NM, German A, Nelson S, Passo MH, Roebuck-Spencer T, et al. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum 2007;57:1174-1182 (Pubitemid 47585463)
20. Holliday SL, Navarrete MG, Hermosillo-Romo D, Valdez CR, Saklad AR, Escalante A, et al. Validating a computerized neuropsychological test battery for mixed ethnic lupus patients. Lupus 2003;12:697-703. (Pubitemid 37173667)
21. McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005;64:297-303.
22. Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol 2008;35:1776-1781
23. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
25. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640
26. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369 (Pubitemid 26085211)
27. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231 (Pubitemid 13158528)
28. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33: 1444-1452
29. Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009;36:1449-1459
30. Thorne DR. Throughput: a simple performance index with desirable characteristics. Behav Res Methods 2006;38:569-573
31. Townsend JT, Ashby FG. Stochastic modeling of elementary psychological processes. New York: Cambridge University Press; 1983.
32. Christie J, Klein R. Familiarity and attention: does what we know affect what we notice? Mem Cognit 1995;23:547-550
33. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-1087
34. Dallow NS, Leonov SL, Roger JH. Practical usage of O'Brien's OLS and GLS statistics in clinical trials. Pharm Stat 2008;7:53-68.
35. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370
36. Waterloo K, Omdal R, Husby G, Mellgren SI. Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) 2002;41:411-415 (Pubitemid 34537839)
37. Hay EM, Huddy A, Black D, Mbaya P, Tomenson B, Bernstein RM, et al. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 1994;53:298-303. (Pubitemid 24164972)
38. Hanly JG, Cassell K, Fisk JD. Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 1997;40:1542-1543 (Pubitemid 27430969)
39. Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, Di Iorio G. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000;247:273-279 (Pubitemid 30223964)
40. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001;45:419-423 (Pubitemid 32979846)
41. Denburg SD, Denburg JA. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 2003; 12:883-890 (Pubitemid 38082082)
42. Hanly JG, Liang MH. Cognitive disorders in systemic lupus erythematosus: epidemiologic and clinical issues. Ann N Y Acad Sci 1997;823:60-68 (Pubitemid 27424887)
43. Reeves DL, Bleiberg J, Roebuck-Spencer T, Cernich AN, Schwab K, Ivins B, et al. Reference values for performance on the Automated Neuropsychological Assessment Metrics V3.0 in an active duty military sample. Mil Med 2006;171:982-994 (Pubitemid 44583083)
44. Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005;19:799-821.
45. Correa DD, Ahles TA. Cognitive adverse effects of chemotherapy in breast cancer patients. Curr Opin Support Palliat Care 2007;1: 57-62.
46. Lofstad GE, Reinfjell T, Hestad K, Diseth TH. Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only. Acta Paediatr 2009;98:180-186